glycine has been researched along with Red-Cell Aplasia, Pure in 4 studies
Red-Cell Aplasia, Pure: Suppression of erythropoiesis with little or no abnormality of leukocyte or platelet production.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 4 (100.00) | 2.80 |
Authors | Studies |
---|---|
Li, S | 1 |
Chen, X | 1 |
Hu, P | 1 |
Wu, S | 1 |
Ma, J | 1 |
Li, Z | 1 |
Wu, X | 1 |
Wen, F | 1 |
Fu, X | 1 |
Feng, Z | 1 |
Tao, Y | 1 |
Li, B | 1 |
Fu, L | 1 |
Huang, R | 1 |
He, C | 1 |
Shi, W | 1 |
Liang, X | 1 |
Liu, S | 1 |
Wu, Y | 1 |
Cai, X | 1 |
Ni, J | 1 |
Lin, X | 1 |
Wan, K | 1 |
Yin, Y | 1 |
Luo, Z | 1 |
Cheng, J | 1 |
Wu, R | 1 |
Peng, Y | 1 |
4 other studies available for glycine and Red-Cell Aplasia, Pure
Article | Year |
---|---|
Roxadustat Improves Erythropoietin Antibody-Mediated Pure Red Cell Aplasia in a Patient with Hemodialysis.
Topics: Aged; Erythropoietin; Glycine; Humans; Isoquinolines; Male; Recombinant Proteins; Red-Cell Aplasia, | 2022 |
Resolution of epoetin-induced pure red cell aplasia, successful re-challenge with roxadustat.
Topics: Adult; Erythropoietin; Glycine; Humans; Isoquinolines; Male; Red-Cell Aplasia, Pure; Renal Insuffici | 2020 |
Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia.
Topics: Erythropoietin; Glycine; Hemoglobins; Humans; Isoquinolines; Male; Middle Aged; Recombinant Proteins | 2021 |
Roxadustat on anti-erythropoietin antibody-related pure red cell aplasia in the patient with end-stage renal disease.
Topics: Adult; Erythropoietin; Female; Glycine; Humans; Isoquinolines; Kidney Failure, Chronic; Recombinant | 2021 |